Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: I just can't see DL letting this happen------------

In the event we, and not TPL, provide working capital funding to PDS we would consolidate PDS’ financial statements with our own as our ownership in PDS would be greater than 50%.

Guess we will wait and see what happens--My eyes are on the Markman!! GL, ads

Share
New Message
Please login to post a reply